Clinical Trials
12 trialsNCT07333976 2026-01-12
o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer
Tri-Service General Hospital
Phase 2 Completed
NCT06135493 2025-04-24
Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients
Future University in Egypt
Phase 2 Completed
NCT05351021 2023-03-09
Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients
Mansoura University
Phase 2 Completed
NCT04565600 2022-02-14
Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib
Guangdong Provincial People's Hospital
Phase 2 Completed
NCT02297412 2022-01-31
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel
Academic and Community Cancer Research United
Phase 2 Completed
NCT01490476 2017-05-23
AFINF2
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT00952848 2017-03-29
Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy
Virginia Commonwealth University
Phase 2 Completed
NCT00891618 2016-10-31
Acupuncture for Chemo-Induced Peripheral Neuropathy
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00365768 2016-09-09
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Columbia University
Phase 2 Completed
NCT01278004 2016-05-26
CINE-E
Royal Marsden NHS Foundation Trust
Phase 2 Completed
NCT00751205 2014-10-28
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)
Bayer
Phase 2 Completed
NCT00041795 2005-06-24
Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy
NeoTherapeutics
Phase 2 Completed